Submitted by Anonymous (not verified) on 23 April 2026 - 15:28
Human medicines European public assessment report (EPAR): Praxbind, idarucizumab, Date of authorisation: 20/11/2015, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Praxbind, idarucizumab, Date of authorisation: 20/11/2015, Revision: 14, Status: Authorised